Metastasis-directed Therapy for Oligorecurrent Prostate Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer — Stella

Recruiting

Back to Prostate Cancer trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Belgium

University Hospitals Leuven, Leuven

Key details

Phase

Large-scale testing

Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment target

~873 participants

Started

April 2022

Primary completion

April 2027

Age range

18 Years and older

Sex

Male only

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov